Bottom line
What is MSPRX's expense ratio?
MSPRX's expense ratio is 1.95%, or about $195 a year on every $10,000 invested. That is more expensive than 92% of large blend funds we track (median 0.83%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Apr 30, 2026
MSPRX fee table
| Net expense ratio | 1.95% |
|---|---|
| Gross expense ratio | 2.03% |
| Management fee | 0.65% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.38% |
| Fee waiver / reimbursement | 0.08% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Apr 30, 2026
What MSPRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MSPRX | $298 | $629 | $1,086 | $2,159 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.95% expense ratio costs roughly $99,500 in lost growth, versus about $46,700 for the median large blend fund (0.83%).